Affiliation:
1. Faculty of Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya City, Japan
2. Intelligent Sensor Technology Inc., Atsugi City, Japan
Abstract
Abstract
Objectives
The aim of this study was to evaluate the bitterness of amlodipine besylate (AML) combined with other five antihypertensive drugs: alacepril, benazepril, hydrochlorothiazide, telmisartan (TEL) and valsartan (VAL), which have possibility of usage as a fixed-dose combination (FDC) drugs.
Methods
The bitterness of individual six drugs and AML combined with each of the five drugs was evaluated using taste sensor SA402B (Intelligent Sensor Technology Inc.). AML combined with TEL or VAL was evaluated by taste sensor and human gustatory sensation tests. The interaction between AML with TEL or VAL was evaluated by 1H-NMR.
Key findings
The bitterness of AML was significantly decreased by addition of VAL, whereas it remained unchanged by the addition of TEL in taste sensor and human gustatory sensation test. In the 1H-NMR spectrum of AML with VAL, signal shifts of protons in AML were observed compared to that in AML alone. On the other hand, in the 1H-NMR spectrum of AML with TEL, signal shifts of protons in AML were not observed.
Conclusions
It was suggested that when VAL was mixed with AML, the electrostatic interactions between positive charged amino group of AML and negative charged tetrazole group of VAL were caused, and thereby led the suppression the bitterness of AML.
Funder
Grant-in-Aid for Scientific Research (C) from Japan Socirty for Promotion of Science
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference25 articles.
1. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8);James;JAMA,2014
2. 2013 ESH/ESC practice guidelines for the management of arterial hypertension;Mancia;Blood Press,2014
3. Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy;Hess;P T,2008
4. Clinical outcomes and healthcare costs in hypertensive patients treated with a fixed-dose combination of amlodipine/valsartan;Tung;J Clin Hypertens,2015
5. Patient adherence to olmesartan/amlodipine combinations: fixed versus extemporaneous combinations;Levi;J Manag Care Spec Pharm,2016
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献